1.Yener U, et al. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.J Neurosurg. 2012 Aug 17. 2. Hope TA, et al. Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model.Magn Reson Imaging. 2012 Aug 13. |